We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

Back to rankings

114 hedge funds and large institutions have $734M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2014 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 37 increasing their positions, 39 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 13

18% more capital invested

Capital invested by funds: $620M → $734M (+$114M)

10% more funds holding

Funds holding: 104 → 114 (+10)

5% less repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 39

Holders
114
Holders Change
+10
Holders Change %
+9.62%
% of All Funds
3.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
37
Reduced
39
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RIM
Ranger Investment Management
Texas
+$15.9M
2
BFA
BlackRock Fund Advisors
California
+$7.18M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$5.27M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$4.76M
5
TCM
Timpani Capital Management
Wisconsin
+$3.63M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$17.1M
2
BC
Broadfin Capital
New York
-$8.54M
3
NIMC
NWQ Investment Management Company
California
-$7.71M
4
Millennium Management
Millennium Management
New York
-$5.39M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$5.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
51
Credit Suisse
Switzerland
$958K -$80.3K -2,966 -9%
ProShare Advisors
52
ProShare Advisors
Maryland
$799K -$116K -4,292 -14%
CCM
53
Catapult Capital Management
New York
$778K -$1.08M -40,000 -62%
WMSA
54
Weiss Multi-Strategy Advisers
New York
$778K -$1.08M -40,000 -62%
MAA
55
Managed Account Advisors
New Jersey
$753K -$453K -16,721 -41%
AI
56
Analytic Investors
California
$737K -$45.2K -1,668 -7%
PAMU
57
Pictet Asset Management (UK)
United Kingdom
$728K -$86.7K -3,200 -12%
Comerica Bank
58
Comerica Bank
Texas
$693K +$604K +22,284 New
GA
59
Geneva Advisors
Illinois
$692K – – –
RhumbLine Advisers
60
RhumbLine Advisers
Massachusetts
$686K +$6.77K +250 +1%
TPSF
61
Texas Permanent School Fund
Texas
$639K -$32.2K -1,189 -5%
Swiss National Bank
62
Swiss National Bank
Switzerland
$634K – – –
DekaBank Deutsche Girozentrale
63
DekaBank Deutsche Girozentrale
Germany
$582K +$10.8K +400 +2%
HW
64
Hancock Whitney
Mississippi
$540K +$470K +17,359 New
MLICM
65
Metropolitan Life Insurance Company (MetLife)
New York
$538K – – –
AIG
66
American International Group
New York
$525K +$69.7K +2,574 +18%
NFA
67
Nationwide Fund Advisors
Ohio
$523K +$4.01K +148 +0.9%
ASRS
68
Arizona State Retirement System
Arizona
$488K -$16.3K -600 -4%
VOYA Investment Management
69
VOYA Investment Management
Georgia
$442K – – –
Asset Management One
70
Asset Management One
Japan
$427K – – –
BA
71
BlackRock Advisors
Delaware
$399K -$7.34K -271 -2%
Tudor Investment Corp
72
Tudor Investment Corp
Connecticut
$395K -$149K -5,500 -30%
Bank of Montreal
73
Bank of Montreal
Ontario, Canada
$390K -$4.39K -162 -1%
PPA
74
Parametric Portfolio Associates
Washington
$373K +$325K +12,003 New
BG
75
BlackRock Group
United Kingdom
$357K +$301K +11,107 +2,777%
1 2
3
4 5

SGNT Hedge Fund Activity: Q3 2014 in Review

114 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q3 2014, worth a combined $734M — up 18% from $620M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new SGNT positions and 13 closed out — a net gain of 10 holders — while 37 added to existing stakes and 39 trimmed.

The largest buyer was Ranger Investment Management, opening a new position worth an estimated $15.9M. The largest seller was Franklin Resources, cutting an estimated $17.1M.

  • 114 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q3 2014, up from 104 in Q2 2014.
  • Funds reported $734M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q3 2014, up 18% quarter-over-quarter.
  • 23 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q3 2014 and 13 closed out, a net change of +10 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q3 2014 was Ranger Investment Management, an estimated $15.9M added.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q3 2014 was Franklin Resources, an estimated $17.1M sold.

Based on aggregated 13F filings for Q3 2014.